CTRI/2013/07/003822已完成4 期
An open label, single centered study to evaluate the efficacy of a cosmetic/ayurvedic formulation in the treatment of Miliaria (Prickly Heat) on affected children subjects.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Volunteer in generally good health.
- •2.Volunteer between the ages of 05 to 12 years.
- •3.Volunteer with primary miliaria.
- •4.Volunteer has not participated in a similar clinical investigation in the past four weeks.
- •5.Volunteer willing to abstain from using any cosmetic/medical product on the test site during the entire study course.
- •6.Volunteer willing to visit the site on scheduled visit.
- •7.Volunteer willing to give a sign a written assent form and come for regular observation.
排除标准
- •1.A known history or present condition of allergic response to any cosmetic products.
- •2.Skin disease except Miliaria (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations), which would interfere with the test readings.
- •3.Medications (e.g. steroids or antihistamines), which would compromise the study.
- •4.Currently or has been undergoing dermatologist treatments or procedures within the last 1 month.
- •5.Volunteer viewed by the investigator as not being able to complete the study or participating in another study.
研究者
相似试验
已完成
不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of LEE011 after a single oral dose of 600 mg [14C]LEE011 (0.37 MBq) in healthy male subjectsgevorderde kankeradvance cancerNL-OMON40904ovartis6
已完成
不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of HDM201 (Siremadlin) after a single oral dose of 25 mg [14C]HDM201 in healthy subjects10027656CancerNL-OMON49451ovartis Pharma AG5
已完成
不适用
A single-center, open-label study to investigate the mass balance, excretion pathways, and metabolites after a single oral dose of 500 mg, 3.7 MBq, [14C]BTZ-043 in healthy male volunteersTuberculosisNL-OMON50849niversity Hospital LMU Klinikum4
已完成
不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of INC280 after a single oral dose of 600 mg [14C] INC280 (5.55 MBq) in healthy male subjectscancerNL-OMON41012ovartis6
撤回
1 期
A single centre open-label study to evaluate the tolerability and safety of a synthetic injectable soft tissue implant material (Family C Matrix) in the skin of normal volunteers.Tolerability & safety of a new synthetic soft tissue implant material.Other - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12608000003370Cosmetrend Pty Ltd14